DGAP-News: Angstrom Pharmaceuticals, Inc. release
Angstrom Pharmaceuticals, Inc.
26.10.2011 16:59
—————————————————————————
Angstrom Pharmaceuticals Announces Publication of the Discovery of the Cellular
Target of Its A6 Phase II Clinical Compound Resulting From Its Joint Study With
Apricus Biosciences
Preclinical Results Elucidate the Mechanism of Action of A6 Peptide in Blocking
Cancer Cell Migration
SAN DIEGO, 2011-10-26 16:42 CEST (GLOBE NEWSWIRE) — Angstrom Pharmaceuticals,
Inc. (
